Dr. Jacob Thomas, MD
Claim this profileUSC Norris Comprehensive Cancer Center
Studies Squamous Cell Carcinoma
Studies Cancer
22 reported clinical trials
32 drugs studied
Area of expertise
1Squamous Cell Carcinoma
Stage IV
Stage III
PD-L1 positive
2Cancer
Stage IV
Stage III
TSC1 positive
Affiliated Hospitals
Clinical Trials Jacob Thomas, MD is currently running
MT-6402
for Solid Cancers
This will be a Phase 1 Open-label, dose escalation and expansion study of MT-6402 (an Engineered Toxin Body (ETB)) in subjects with advanced solid cancer that expresses PD-L1
Recruiting1 award Phase 110 criteria
CAB-ROR2-ADC + PD-1 Inhibitor
for Breast Cancer
This trial is testing a new targeted cancer treatment called CAB-ROR2-ADC in patients with advanced solid tumors. The drug seeks out cancer cells with a specific marker and delivers a potent treatment directly to them.
Recruiting1 award Phase 1 & 29 criteria
More about Jacob Thomas, MD
Clinical Trial Related1 year of experience running clinical trials · Led 22 trials as a Principal Investigator · 17 Active Clinical TrialsTreatments Jacob Thomas, MD has experience with
- Nivolumab
- PD-1 Inhibitor
- MT-6402
- Cemiplimab
- Resection
- Tumor Resection
Breakdown of trials Jacob Thomas, MD has run
Squamous Cell Carcinoma
Cancer
Solid Tumors
Head and Neck Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jacob Thomas, MD specialize in?
Jacob Thomas, MD focuses on Squamous Cell Carcinoma and Cancer. In particular, much of their work with Squamous Cell Carcinoma has involved Stage IV patients, or patients who are Stage III.
Is Jacob Thomas, MD currently recruiting for clinical trials?
Yes, Jacob Thomas, MD is currently recruiting for 16 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Jacob Thomas, MD has studied deeply?
Yes, Jacob Thomas, MD has studied treatments such as Nivolumab, PD-1 inhibitor, MT-6402.
What is the best way to schedule an appointment with Jacob Thomas, MD?
Apply for one of the trials that Jacob Thomas, MD is conducting.
What is the office address of Jacob Thomas, MD?
The office of Jacob Thomas, MD is located at: USC Norris Comprehensive Cancer Center, Los Angeles, California 90033 United States. This is the address for their practice at the USC Norris Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.